
Injection · 6 mg/mL

A daily GLP-1 injection that slows stomach emptying and reduces appetite signalling. Because it clears the body faster than weekly options, side effects tend to be shorter-lived and the dose is easier to fine-tune. The trade-off is an injection every day rather than once a week.


Answer a few health questions — a licensed provider reviews online. No waiting rooms.

Once approved, your medication ships discreetly to your door.


Physician-guided support and check-ins keep results on track.

Inject subcutaneously once daily, starting at 0.6 mg and increasing weekly as tolerated toward the maintenance dose set by your clinician
Liraglutide caused thyroid C-cell tumors in rats and mice. Whether that happens in people is not known.
Tell your care team straight away if you feel a lump or swelling in your neck, your voice goes hoarse or swallowing becomes hard, you get severe stomach pain that will not stop, you cannot keep up with vomiting or diarrhea, you get pain in your upper right belly or your eyes turn yellow, or your face or lips swell.
Common side effects
Rare but serious
Do not take this if you or a family member has had medullary thyroid carcinoma, you have Multiple Endocrine Neoplasia syndrome type 2, or you have reacted badly to liraglutide before.
This is not a complete list of side effects. Message your care team about any symptom that worries you. What we dispense is a compounded preparation made by a licensed US pharmacy. Compounded medications are not approved by the FDA for safety, efficacy or quality.
Liraglutide is taken once daily rather than once weekly. It leaves the body faster, so side effects tend to be shorter-lived and the dose is easier to adjust — but it asks for a daily habit rather than a weekly one.
Typically in weekly steps, starting low. The early weeks are about tolerance rather than results, and rushing the titration is the most common reason people stop.
Nausea, constipation and diarrhoea, usually worst in the days after each increase. Smaller meals eaten slowly help considerably.
It is not appropriate with a personal or family history of medullary thyroid carcinoma or MEN 2, or in pregnancy. Your intake covers the full list.

Globally recognized aging biologist and former CEO of the Buck Institute for Research on Aging, renowned for pioneering research on sirtuins, mTOR, and healthy aging.

World-leading biogerontologist and Founding Director of the Healthy Aging & Longevity Research Institute, celebrated for uncovering the biological mechanisms of aging.

Board-certified Family Nurse Practitioner with 15+ years of clinical experience, specializing in preventative wellness and biomarker-driven personalized care.